Literature DB >> 15006691

Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion.

Davy Yeung1, Riddhi Kharidia, Susan C Brown, Dariusz C Górecki.   

Abstract

Following molecular and immunohistochemical analysis of the purinergic P2X4 receptor subunit in dystrophin-deficient muscle we have identified a distinct subpopulation of P2X4-positive cells infiltrating the dystrophic fibres. These cells were absent from normal muscle and rarely present in the dystrophic muscle taken before and after the onset of degeneration. We have identified these P2X4-positive cells as macrophages, demonstrating for the first time that human and mouse tissue macrophages express P2X4 in addition to P2X7 receptor subunits both in vitro and in situ. Moreover, we have demonstrated that the increase in the P2X4 expression is yet another feature of an inflammatory response identified in DNA arrays of dystrophic muscle. Immunohistochemical analysis failed to localise discernible expression of P2X4 protein in adult skeletal or cardiac muscle fibres, whilst myoblasts in culture expressed low levels of this subunit, as detected by RT-PCR and Western blotting. In light of the involvement of macrophages in the dystrophic process, the function of P2X receptors and their role in the Duchenne pathology as well as their potential role in therapeutic applications are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006691     DOI: 10.1016/j.nbd.2003.10.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

1.  The role of P2 receptors in controlling infections by intracellular pathogens.

Authors:  Robson Coutinho-Silva; Cristiane Monteiro da Cruz; Pedro M Persechini; David M Ojcius
Journal:  Purinergic Signal       Date:  2007-01-12       Impact factor: 3.765

2.  Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice.

Authors:  Eléonore Bertin; Thomas Deluc; Kjara S Pilch; Audrey Martinez; Johan-Till Pougnet; Evelyne Doudnikoff; Anne-Emilie Allain; Philine Bergmann; Marion Russeau; Estelle Toulmé; Erwan Bezard; Friedrich Koch-Nolte; Philippe Séguéla; Sabine Lévi; Bruno Bontempi; François Georges; Sandrine S Bertrand; Olivier Nicole; Eric Boué-Grabot
Journal:  Mol Psychiatry       Date:  2020-01-08       Impact factor: 15.992

3.  P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment.

Authors:  Christopher N J Young; Wojciech Brutkowski; Chun-Fu Lien; Stephen Arkle; Hanns Lochmüller; Krzysztof Zabłocki; Dariusz C Górecki
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

4.  P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.

Authors:  Anthony Sinadinos; Christopher N J Young; Rasha Al-Khalidi; Anna Teti; Paweł Kalinski; Shafini Mohamad; Léonore Floriot; Tiphaine Henry; Gianluca Tozzi; Taiwen Jiang; Olivier Wurtz; Alexis Lefebvre; Mikhail Shugay; Jie Tong; David Vaudry; Stephen Arkle; Jean-Claude doRego; Dariusz C Górecki
Journal:  PLoS Med       Date:  2015-10-13       Impact factor: 11.069

5.  Macrophage density in pharyngeal and laryngeal muscles greatly exceeds that in other striated muscles: an immunohistochemical study using elderly human cadavers.

Authors:  Sunki Rhee; Masahito Yamamoto; Kei Kitamura; Kasahara Masaaki; Yukio Katori; Gen Murakami; Shin-Ichi Abe
Journal:  Anat Cell Biol       Date:  2016-09-29

6.  Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.

Authors:  Francisco Altamirano; Denisse Valladares; Carlos Henríquez-Olguín; Mariana Casas; Jose R López; Paul D Allen; Enrique Jaimovich
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

7.  Transcriptomic profiling of feline teeth highlights the role of matrix metalloproteinase 9 (MMP9) in tooth resorption.

Authors:  S Lee; S J Bush; S Thorne; N Mawson; C Farquharson; G T Bergkvist
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.